Literature DB >> 23527706

IL-36 receptor antagonist with special emphasis on IL-38.

Y Shaik, G Sabatino, G Maccauro, G Varvara, G Murmura, A Saggini, M Rosati, F Conti, E Cianchetti, A Caraffa, P Antinolfi, F Pandolfi, G Potalivo, R Galzio, P Conti, T C Theoharides.   

Abstract

IL-36 is another family member of IL-1 and induces the production of proinflammatory cytokines and activates MAPK and NFkB pathways. IL-36 is a common mediator of innate and adaptive immune response and is inhibited by IL-36 receptor antagonist (RA). IL-36RA acts on IL-36 receptor ligand which exerts proinflammatory effect in vivo and in vitro. IL-38 binds to IL-36 receptor as does IL-36RA and has similar biological effects on immune cells. IL-38 is also a member of IL-1 cytokine and shares some characteristics of IL-1RA, binding the same IL-1 receptor type I. IL-38 plays a role in the pathogenesis of inflammatory diseases, exerting protective effect in some autoimmune diseases. Both IL-38 and IL-36RA have an anti-inflammatory biological effect, however in some cases have contrary effects.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23527706     DOI: 10.1177/039463201302600103

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  4 in total

Review 1.  Immunobiological Properties and Clinical Applications of Interleukin-38 for Immune-Mediated Disorders: A Systematic Review Study.

Authors:  Abdolreza Esmaeilzadeh; Nazila Bahmaie; Elham Nouri; Mohammad Javad Hajkazemi; Maryam Zareh Rafie
Journal:  Int J Mol Sci       Date:  2021-11-21       Impact factor: 5.923

Review 2.  Therapeutic use of dendritic cells to promote the extranodal priming of anti-tumor immunity.

Authors:  Lu Chen; Kellsye L Fabian; Jennifer L Taylor; Walter J Storkus
Journal:  Front Immunol       Date:  2013-11-29       Impact factor: 7.561

3.  Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies.

Authors:  Rajkumar Ganesan; Ernest L Raymond; Detlev Mennerich; Joseph R Woska; Gary Caviness; Christine Grimaldi; Jennifer Ahlberg; Rocio Perez; Simon Roberts; Danlin Yang; Kavita Jerath; Kristopher Truncali; Lee Frego; Eliud Sepulveda; Priyanka Gupta; Su-Ellen Brown; Michael D Howell; Keith A Canada; Rachel Kroe-Barrett; Jay S Fine; Sanjaya Singh; M Lamine Mbow
Journal:  MAbs       Date:  2017-07-20       Impact factor: 5.857

4.  IL-38 Alleviates Inflammation in Sepsis in Mice by Inhibiting Macrophage Apoptosis and Activation of the NLRP3 Inflammasome.

Authors:  Yun Ge; Juan Chen; Yanting Hu; Xinyi Chen; Man Huang
Journal:  Mediators Inflamm       Date:  2021-12-17       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.